Fresh analysis reveals that people who stop using new slimming jabs like semaglutide or tirzepatide may regain lost weight far faster than those who stop traditional diet and exercise regimens.
Findings released in a leading health publication demonstrates that while obese individuals often shed a large proportion of their total mass while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals using these medications need to be informed of the potential of rapid weight regain when the treatment concludes," warns lead investigator Dr. Susan Jebb.
That rate of recovery implies a reversion to starting weight in about a year and a half.
Analyzing Treatments
The study, which reviewed 37 of trials involving thousands of patients, compared the outcomes of GLP-1 agonists with other pills.
Scientists emphasize that individuals who lose weight through diet and exercise usually see a slower weight regain—perhaps 0.1 kg a month—once they finish.
Explaining the Quick Rebound
Experts suggest the mechanism of the jabs is key to understanding the accelerated weight return.
The injections copy a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production may cause the body to produce less of its endogenous GLP-1, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication means appetite is no longer kept in check, making excessive eating far more likely."
A Chronic Condition?
Health authorities recommend the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Many experts contend that, given the significant potential of relapse, the therapy is often ongoing.
This view is supported by drug manufacturers, who say that the results "highlight the persistent character of excess weight," akin to managing diseases like hypertension.
Patient Testimonies
Users who have stopped the jabs report a intense resurgence of cravings.
"It was like a switch that goes on and you become starving," described an individual.
This challenge is worsened if individuals have not developed permanent lifestyle or habit changes during therapy.
Significant Adoption
Survey data suggest that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is higher among women compared to men.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians stress that while the jabs are potent tools for shedding pounds, they are not a standalone cure and lasting health benefits hinges on ongoing lifestyle support.